Long Noncoding RNAs in Diffuse Large B-Cell Lymphoma: Current Advances and Perspectives

References

• Pasqualucci L, Dalla-Favera R. Genetics of diffuse large B-cell lymphoma. Blood. 2018;131(21):2307–2319. doi:10.1182/blood-2017-11-76433229666115
   PubMed Web of Science ®Google Scholar
• Smith A, Howell D, Patmore R, Jack A, Roman E. Incidence of haematological malignancy by sub-type: a report from the Haematological Malignancy Research Network. Br J Cancer. 2011;105(11):1684–1692. doi:10.1038/bjc.2011.45022045184
   PubMed Web of Science ®Google Scholar
• Feugier P, Van Hoof A, Sebban C, et al. Long-term results of the R-CHOP study in the treatment of elderly patients with diffuse large B-cell lymphoma: a study by the Groupe d’Etude des Lymphomes de l’Adulte. J Clin Oncol. 2005;23(18):4117–4126. doi:10.1200/JCO.2005.09.13115867204
   PubMed Web of Science ®Google Scholar
• Roschewski M, Staudt LM, Wilson WH. Diffuse large B-cell lymphoma-treatment approaches in the molecular era. Nat Rev Clin Oncol. 2014;11(1):12–23. doi:10.1038/nrclinonc.2013.19724217204
   PubMed Web of Science ®Google Scholar
• Coiffier B, Sarkozy C. Diffuse large B-cell lymphoma: R-CHOP failure-what to do? Hematology Am Soc Hematol Educ Program. 2016;2016(1):366–378. doi:10.1182/asheducation-2016.1.36627913503
   PubMed Web of Science ®Google Scholar
• Wright MW, Bruford EA. Naming ‘junk’: human non-protein coding RNA (ncRNA) gene nomenclature. Hum Genomics. 2011;5(2):90–98. doi:10.1186/1479-7364-5-2-9021296742
   PubMedGoogle Scholar
• Anastasiadou E, Jacob LS, Slack FJ. Non-coding RNA networks in cancer. Nat Rev Cancer. 2018;18(1):5–18. doi:10.1038/nrc.2017.9929170536
   PubMed Web of Science ®Google Scholar
• Spizzo R, Almeida MI, Colombatti A, Calin GA. Long non-coding RNAs and cancer: a new frontier of translational research? Oncogene. 2012;31(43):4577–4587. doi:10.1038/onc.2011.62122266873
   PubMed Web of Science ®Google Scholar
• Bhan A, Soleimani M, Mandal SS. Long noncoding RNA and cancer: a new paradigm. Cancer Res. 2017;77(15):3965–3981. doi:10.1158/0008-5472.CAN-16-263428701486
   PubMed Web of Science ®Google Scholar
• Quinn JJ, Chang HY. Unique features of long non-coding RNA biogenesis and function. Nat Rev Genet. 2016;17(1):47–62. doi:10.1038/nrg.2015.1026666209
   PubMed Web of Science ®Google Scholar
• Guttman M, Amit I, Garber M, et al. Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals. Nature. 2009;458(7235):223–227. doi:10.1038/nature0767219182780
   PubMed Web of Science ®Google Scholar
• Hezroni H, Koppstein D, Schwartz MG, Avrutin A, Bartel DP, Ulitsky I. Principles of long noncoding RNA evolution derived from direct comparison of transcriptomes in 17 species. Cell Rep. 2015;11(7):1110–1122. doi:10.1016/j.celrep.2015.04.02325959816
   PubMed Web of Science ®Google Scholar
• Iyer MK, Niknafs YS, Malik R, et al. The landscape of long noncoding RNAs in the human transcriptome. Nat Genet. 2015;47(3):199–208. doi:10.1038/ng.319225599403
   PubMed Web of Science ®Google Scholar
• Harrow J, Frankish A, Gonzalez JM, et al. GENCODE: the reference human genome annotation for The ENCODE Project. Genome Res. 2012;22(9):1760–1774. doi:10.1101/gr.135350.11122955987
   PubMed Web of Science ®Google Scholar
• Derrien T, Johnson R, Bussotti G, et al. The GENCODE v7 catalog of human long noncoding RNAs: analysis of their gene structure, evolution, and expression. Genome Res. 2012;22(9):1775–1789. doi:10.1101/gr.132159.11122955988
   PubMed Web of Science ®Google Scholar
• Cabili MN, Trapnell C, Goff L, et al. Integrative annotation of human large intergenic noncoding RNAs reveals global properties and specific subclasses. Genes Dev. 2011;25(18):1915–1927. doi:10.1101/gad.1744661121890647
   PubMed Web of Science ®Google Scholar
• Li F, Xiao Y, Huang F, et al. Spatiotemporal-specific lncRNAs in the brain, colon, liver and lung of macaque during development. Mol Biosyst. 2015;11(12):3253–3263. doi:10.1039/C5MB00474H26456323
   PubMedGoogle Scholar
• Guttman M, Rinn JL. Modular regulatory principles of large non-coding RNAs. Nature. 2012;482(7385):339–346. doi:10.1038/nature1088722337053
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, Kats L, Pandolfi PP. A ceRNA hypothesis: the rosetta stone of a hidden RNA language? Cell. 2011;146(3):353–358. doi:10.1016/j.cell.2011.07.01421802130
   PubMed Web of Science ®Google Scholar
• Jeon Y, Lee JT. YY1 tethers Xist RNA to the inactive X nucleation center. Cell. 2011;146(1):119–133. doi:10.1016/j.cell.2011.06.02621729784
   PubMed Web of Science ®Google Scholar
• Rinn JL, Chang HY. Genome regulation by long noncoding RNAs. Annu Rev Biochem. 2012;81(1):145–166. doi:10.1146/annurev-biochem-051410-09290222663078
   PubMed Web of Science ®Google Scholar
• Ørom UA, Derrien T, Beringer M, et al. Long noncoding RNAs with enhancer-like function in human cells. Cell. 2010;143(1):46–58. doi:10.1016/j.cell.2010.09.00120887892
   PubMed Web of Science ®Google Scholar
• International Non-Hodgkin’s Lymphoma Prognostic Factors Project. A predictive model for aggressive non-hodgkin’s lymphoma. N Engl J Med. 1993;329(14):987–994. doi:10.1056/NEJM1993093032914028141877
   PubMed Web of Science ®Google Scholar
• Clausen MR, Maurer MJ, Ulrichsen SP, et al. Pretreatment hemoglobin adds prognostic information to the NCCN-IPI in patients with diffuse large B-cell lymphoma treated with anthracycline-containing chemotherapy. Clin Epidemiol. 2019;11:987–996. doi:10.2147/CLEP.S21959531814771
   PubMed Web of Science ®Google Scholar
• Goto N, Tsurumi H, Kasahara S, et al. Serum interleukin-18 level is associated with the outcome of patients with diffuse large B-cell lymphoma treated with CHOP or R-CHOP regimens. Eur J Haematol. 2011;87(3):217–227. doi:10.1111/j.1600-0609.2011.01649.x21575062
   PubMed Web of Science ®Google Scholar
• Verma A, Jiang Y, Du W, Fairchild L, Melnick A, Elemento O. Transcriptome sequencing reveals thousands of novel long non-coding RNAs in B cell lymphoma. Genome Med. 2015;7(1):110. doi:10.1186/s13073-015-0230-726521025
   PubMedGoogle Scholar
• Gao HY, Wu B, Yan W, et al. Microarray expression profiles of long non-coding RNAs in germinal center-like diffuse large B-cell lymphoma. Oncol Rep. 2017;38(3):1363–1372. doi:10.3892/or.2017.582128713985
   PubMed Web of Science ®Google Scholar
• Zhu D, Fang C, Li X, et al. Predictive analysis of long non-coding RNA expression profiles in diffuse large B-cell lymphoma. Oncotarget. 2017;8(14):23228–23236. doi:10.18632/oncotarget.1557128423571
   PubMedGoogle Scholar
• Zhou M, Zhao H, Xu W, Bao S, Cheng L, Sun J. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma. Mol Cancer. 2017;16(1):16. doi:10.1186/s12943-017-0580-428103885
   PubMedGoogle Scholar
• Sun J, Cheng L, Shi H, et al. A potential panel of six-long non-coding RNA signature to improve survival prediction of diffuse large-B-cell lymphoma. Sci Rep. 2016;6(1):27842. doi:10.1038/srep2784227292966
   PubMedGoogle Scholar
• Dousti F, Shahrisa A, Ansari H, et al. Long non-coding RNAs expression levels in diffuse large B-cell lymphoma: an in silico analysis. Pathol Res Pract. 2018;214(9):1462–1466. doi:10.1016/j.prp.2018.08.00630104077
   PubMed Web of Science ®Google Scholar
• Xu P, Chen X, Su P. A pooled analysis of the clinical utilities of long non-coding RNA based molecular signature for diffuse large B cell lymphoma. Clin Lab. 2017;63(11+12/2017):1831–1840. doi:10.7754/Clin.Lab.2017.17060529226652
   PubMed Web of Science ®Google Scholar
• Gupta RA, Shah N, Wang KC, et al. Long non-coding RNA HOTAIR reprograms chromatin state to promote cancer metastasis. Nature. 2010;464(7291):1071–1076. doi:10.1038/nature0897520393566
   PubMed Web of Science ®Google Scholar
• Yan Y, Han J, Li Z, Yang H, Sui Y, Wang M. Elevated RNA expression of long non‑coding HOTAIR promotes cell proliferation and predicts a poor prognosis in patients with diffuse large B cell lymphoma. Mol Med Rep. 2016;13(6):5125–5131. doi:10.3892/mmr.2016.519027122348
   PubMed Web of Science ®Google Scholar
• Oh EJ, Kim SH, Yang WI, Ko YH, Yoon SO. Long non-coding RNA HOTAIR expression in diffuse large B-cell lymphoma: in relation to polycomb repressive complex pathway proteins and H3K27 trimethylation. J Pathol Transl Med. 2016;50(5):369–376. doi:10.4132/jptm.2016.06.0627550047
   PubMedGoogle Scholar
• Lin Y, Fang Z, Lin Z, et al. The prognostic impact of long noncoding RNA HOTAIR in leukemia and lymphoma: a meta-analysis. Hematology. 2018;23(9):600–607. doi:10.1080/10245332.2018.144657229513085
   PubMed Web of Science ®Google Scholar
• Shi X, Cui Z, Liu X, et al. LncRNA FIRRE is activated by MYC and promotes the development of diffuse large B-cell lymphoma via Wnt/β-catenin signaling pathway. Biochem Biophys Res Commun. 2019;510(4):594–600. doi:10.1016/j.bbrc.2019.01.10530739786
   PubMed Web of Science ®Google Scholar
• Deng L, Jiang L, Tseng KF, et al. Aberrant NEAT1_1 expression may be a predictive marker of poor prognosis in diffuse large B cell lymphoma. Cancer Biomark. 2018;23(2):157–164. doi:10.3233/CBM-16022130175971
   PubMed Web of Science ®Google Scholar
• Tang JL, Li XM, Zhang L. Expression and significance of lncRNA RP11-513G11.1 in peripheral blood of patients with diffuse large B-cell lymphoma. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2019;27(5):1515–1521. doi:10.19746/j.cnki.issn.1009-2137.2019.05.02431607306
   PubMedGoogle Scholar
• Zhao S, Fang S, Liu Y, et al. The long non-coding RNA NONHSAG026900 predicts prognosis as a favorable biomarker in patients with diffuse large B-cell lymphoma. Oncotarget. 2017;8(21):34374–34386. doi:10.18632/oncotarget.1616328423735
   PubMedGoogle Scholar
• Wang Y, Zhang M, Xu H, et al. Discovery and validation of the tumor-suppressive function of long noncoding RNA PANDA in human diffuse large B-cell lymphoma through the inactivation of MAPK/ERK signaling pathway. Oncotarget. 2017;8(42):72182–72196. doi:10.18632/oncotarget.2005329069778
   PubMedGoogle Scholar
• Peng W, Wu J, Feng J. LincRNA-p21 predicts favorable clinical outcome and impairs tumorigenesis in diffuse large B cell lymphoma patients treated with R-CHOP chemotherapy. Clin Exp Med. 2017;17(1):1–8. doi:10.1007/s10238-015-0396-826475621
   PubMed Web of Science ®Google Scholar
• Zhao L, Liu Y, Zhang J, Liu Y, Qi Q. LncRNA SNHG14/miR-5590-3p/ZEB1 positive feedback loop promoted diffuse large B cell lymphoma progression and immune evasion through regulating PD-1/PD-L1 checkpoint. Cell Death Dis. 2019;10(10):731. doi:10.1038/s41419-019-1886-531570691
   PubMed Web of Science ®Google Scholar
• Zhu Q, Li Y, Guo Y, et al. Long non-coding RNA SNHG16 promotes proliferation and inhibits apoptosis of diffuse large B-cell lymphoma cells by targeting miR-497-5p/PIM1 axis. J Cell Mol Med. 2019;23(11):7395–7405. doi:10.1111/jcmm.1460131483572
   PubMed Web of Science ®Google Scholar
• Cheng H, Yan Z, Wang X, et al. Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma. Mol Cell Biochem. 2019;461(1–2):47–56. doi:10.1007/s11010-019-03588-731338678
   PubMed Web of Science ®Google Scholar
• Wang QM, Lian GY, Song Y, Huang YF, Gong Y. LncRNA MALAT1 promotes tumorigenesis and immune escape of diffuse large B cell lymphoma by sponging miR-195. Life Sci. 2019;231:116335. doi:10.1016/j.lfs.2019.03.04030898647
   PubMed Web of Science ®Google Scholar
• Zhao CC, Jiao Y, Zhang YY, et al. Lnc SMAD5-AS1 as ceRNA inhibit proliferation of diffuse large B cell lymphoma via Wnt/β-catenin pathway by sponging miR-135b-5p to elevate expression of APC. Cell Death Dis. 2019;10(4):252. doi:10.1038/s41419-019-1479-330874550
   PubMed Web of Science ®Google Scholar
• Li LJ, Chai Y, Guo XJ, Chu SL, Zhang LS. The effects of the long non-coding RNA MALAT-1 regulated autophagy-related signaling pathway on chemotherapy resistance in diffuse large B-cell lymphoma. Biomed Pharmacother. 2017;89:939–948. doi:10.1016/j.biopha.2017.02.01128292022
   PubMed Web of Science ®Google Scholar
• Han Y, Zhou S, Wang X, Mao E, Huang L. SNHG14 stimulates cell autophagy to facilitate cisplatin resistance of colorectal cancer by regulating miR-186/ATG14 axis. Biomed Pharmacother. 2020;121:109580. doi:10.1016/j.biopha.2019.10958031704614
   PubMed Web of Science ®Google Scholar
• Qian J, Huang X, Zhang Y, Ye X, Qian W. γ-catenin overexpression in AML patients may promote tumor cell survival via activation of the Wnt/β-catenin axis. Onco Targets Ther. 2020;13:1265–1276. doi:10.2147/OTT.S23087332103994
   PubMed Web of Science ®Google Scholar
• Zhang H, Liao Z, Liu F, et al. Long noncoding RNA HULC promotes hepatocellular carcinoma progression. Aging (Albany NY). 2019;11(20):9111–9127. doi:10.18632/aging.10237831645479
   PubMedGoogle Scholar
• Hu T, Gao Y. β-elemene suppresses tumor growth of diffuse large B-cell lymphoma through regulating lncRNA HULC-mediated apoptotic pathway. Biosci Rep. 2020;40(2):BSR20190804. doi:10.1042/BSR2019080432010942
   PubMedGoogle Scholar
• Wu GS. The functional interactions between the p53 and MAPK signaling pathways. Cancer Biol Ther. 2004;3(2):156–161. doi:10.4161/cbt.3.2.61414764989
   PubMed Web of Science ®Google Scholar
• Tian L, He Y, Zhang H, Wu Z, Li D, Zheng C. Comprehensive analysis of differentially expressed profiles of lncRNAs and mRNAs reveals ceRNA networks in the transformation of diffuse large B-cell lymphoma. Oncol Lett. 2018;16(1):882–890. doi:10.3892/ol.2018.872229963159
   PubMed Web of Science ®Google Scholar
• Pedram Fatemi R, Salah-Uddin S, Modarresi F, Khoury N, Wahlestedt C, Faghihi MA. Screening for small-molecule modulators of long noncoding RNA-protein interactions using AlphaScreen. J Biomol Screen. 2015;20(9):1132–1141. doi:10.1177/108705711559418726173710
   PubMedGoogle Scholar